Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NEKTAR THERAPEUTICS | Chief R&D Officer | Common Stock | 327K | $307K | $0.94 | Dec 19, 2024 | Direct |
NEKTAR THERAPEUTICS | Chief R&D Officer | Stock Option | 375K | Dec 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NKTR | NEKTAR THERAPEUTICS | Dec 19, 2024 | 1 | -$48K | 4 | Dec 20, 2024 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | Dec 13, 2024 | 3 | $0 | 4 | Dec 17, 2024 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | Nov 19, 2024 | 1 | -$7.86K | 4 | Nov 20, 2024 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | Aug 19, 2024 | 1 | -$8.79K | 4 | Aug 20, 2024 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | May 17, 2024 | 1 | -$12.9K | 4 | May 20, 2024 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | Feb 20, 2024 | 1 | -$6.13K | 4 | Feb 22, 2024 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | Dec 13, 2023 | 1 | $0 | 4 | Dec 15, 2023 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | Nov 17, 2023 | 1 | -$4.73K | 4 | Nov 20, 2023 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | Aug 16, 2023 | 1 | -$7.57K | 4 | Aug 17, 2023 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | May 16, 2023 | 1 | -$7.05K | 4 | May 17, 2023 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | Feb 16, 2023 | 1 | -$31.5K | 4 | Feb 17, 2023 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | Nov 16, 2022 | 1 | -$48.1K | 4 | Nov 18, 2022 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | Aug 18, 2022 | 1 | -$343K | 4 | Aug 19, 2022 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | Aug 15, 2022 | 3 | -$50.3K | 4 | Aug 17, 2022 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | May 15, 2022 | 2 | -$85.6K | 4 | May 17, 2022 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | Feb 16, 2022 | 1 | -$119K | 4 | Feb 18, 2022 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | Dec 16, 2021 | 2 | $0 | 4 | Dec 20, 2021 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | Nov 15, 2021 | 2 | -$275K | 4 | Nov 17, 2021 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | Oct 12, 2021 | 1 | $0 | 4 | Oct 14, 2021 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | Aug 16, 2021 | 1 | -$106K | 4 | Aug 18, 2021 | Chief R&D Officer |
NKTR | NEKTAR THERAPEUTICS | May 17, 2021 | 1 | -$569K | 4 | May 19, 2021 | Chief R&D Officer |